Candriam SCA’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.29M | Sell |
9,124
-753
| -8% | -$187K | 0.01% | 498 |
|
|
2025
Q4 | $2.72M | Buy |
9,877
+4,847
| +96% | +$1.33M | 0.01% | 460 |
|
|
2025
Q3 | $1.32M | Sell |
5,030
-740
| -13% | -$180K | 0.01% | 549 |
|
|
2025
Q2 | $1.26M | Sell |
5,770
-543
| -9% | -$116K | 0.01% | 571 |
|
|
2025
Q1 | $1.41M | Sell |
6,313
-662
| -9% | -$182K | 0.01% | 544 |
|
|
2024
Q4 | $2.28M | Buy |
6,975
+823
| +13% | +$259K | 0.01% | 487 |
|
|
2024
Q3 | $1.85M | Buy |
6,152
+434
| +8% | +$133K | 0.01% | 511 |
|
|
2024
Q2 | $1.88M | Sell |
5,718
-4,850
| -46% | -$1.71M | 0.01% | 496 |
|
|
2024
Q1 | $4.18M | Buy |
10,568
+5,167
| +96% | +$1.91M | 0.03% | 371 |
|
|
2023
Q4 | $1.9M | Buy |
5,401
+1,250
| +30% | +$442K | 0.01% | 502 |
|
|
2023
Q3 | $1.55M | Hold |
4,151
| – | – | 0.01% | 485 |
|
|
2023
Q2 | $1.59M | Sell |
4,151
-6,422
| -61% | -$2.29M | 0.01% | 539 |
|
|
2023
Q1 | $3.37M | Sell |
10,573
-13,483
| -56% | -$3.94M | 0.02% | 458 |
|
|
2022
Q4 | $5.66M | Sell |
24,056
-1,449
| -6% | -$343K | 0.04% | 360 |
|
|
2022
Q3 | $6.28M | Sell |
25,505
-31,798
| -55% | -$9.69M | 0.04% | 347 |
|
|
2022
Q2 | $17.3M | Sell |
57,303
-303
| -0.5% | -$98.6K | 0.14% | 156 |
|
|
2022
Q1 | $23.7M | Sell |
57,606
-2,833
| -5% | -$1.11M | 0.16% | 142 |
|
|
2021
Q4 | $28.3M | Buy |
60,439
+6,571
| +12% | +$2.83M | 0.18% | 134 |
|
|
2021
Q3 | $22.9M | Sell |
53,868
-14,891
| -22% | -$6.28M | 0.16% | 154 |
|
|
2021
Q2 | $24.7M | Buy |
68,759
+44,139
| +179% | +$14.6M | 0.17% | 148 |
|
|
2021
Q1 | $6.7M | Hold |
24,620
| – | – | 0.06% | 322 |
|
|
2020
Q4 | $6.97M | Sell |
24,620
-1,037
| -4% | -$291K | 0.06% | 330 |
|
|
2020
Q3 | $7.05M | Sell |
25,657
-5,439
| -17% | -$1.44M | 0.07% | 293 |
|
|
2020
Q2 | $7.06M | Buy |
+31,096
| New | +$6.11M | 0.07% | 276 |
|
Other funds holding WST
VCM
VPM
GIM
